» Articles » PMID: 9637512

Structural and Functional Analysis of J Chain-deficient IgM

Overview
Journal J Immunol
Date 1998 Jun 24
PMID 9637512
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Previous studies have discerned two forms of polymeric mouse IgM: moderately cytolytic (complement-activating) pentamer, which contains J chain, and highly cytolytic hexamer, which lacks J chain. To investigate the relationships among polymeric structure, J chain content, and cytolytic activity, we produced IgM in J chain-deficient and J chain-proficient mouse hybridoma cell lines. Both hexamer and pentamer were produced in the absence as well as the presence of J chain. Hexameric IgM activated (guinea pig) complement approximately 100-fold more efficiently than did J chain-deficient pentamer, which, in turn, was more active than J chain-containing pentamer. These results are consistent with the hypothesis that J chain-containing pentamer cannot activate complement. We also analyzed the structure of IgM-S337, in which the mu-chain bears the C337S substitution. Like normal IgM, IgM-S337 was formed as a hexamer and as both J chain deficient- and J chain-containing pentamers. Unlike normal IgM, IgM-S337 dissociated in SDS into various subunits. For IgM-S337 pentamer, the predominant subunits migrated as mu2kappa2 and mu4kappa4, and the subunit distribution was unaltered by J chain. However, J chain was found only in the mu2kappa2 species, suggesting that some arrangement of inter-mu bonds directs incorporation of J chain. IgM-S337 hexamer also dissociated to mu2kappa2 and mu4kappa4, but also yielded several species migrating much more slowly in SDS-PAGE than wild-type mu12kappa12. To account for these forms, we propose that each mu-chain can interact with three other mu-chains and that some hexameric molecules contain two catenated mu6kappa6 circles.

Citing Articles

Absolute Quantification of Pan-Cancer Plasma Proteomes Reveals Unique Signature in Multiple Myeloma.

Kotol D, Woessmann J, Hober A, Alvez M, Tran Minh K, Ponten F Cancers (Basel). 2023; 15(19).

PMID: 37835457 PMC: 10571728. DOI: 10.3390/cancers15194764.


Interplay between Liposomes and IgM: Principles, Challenges, and Opportunities.

Wang H, Lin S, Wu X, Jiang K, Lu H, Zhan C Adv Sci (Weinh). 2023; 10(20):e2301777.

PMID: 37150860 PMC: 10369250. DOI: 10.1002/advs.202301777.


A Zika virus-specific IgM elicited in pregnancy exhibits ultrapotent neutralization.

Singh T, Hwang K, Miller A, Jones R, Lopez C, Dulson S Cell. 2022; 185(25):4826-4840.e17.

PMID: 36402135 PMC: 9742325. DOI: 10.1016/j.cell.2022.10.023.


Biophysical Characterization of the Oligomeric States of Recombinant Immunoglobulins Type-M and Their C1q-Binding Kinetics by Biolayer Interferometry.

Chouquet A, Pinto A, Hennicke J, Ling W, Bally I, Schwaigerlehner L Front Bioeng Biotechnol. 2022; 10:816275.

PMID: 35685087 PMC: 9173649. DOI: 10.3389/fbioe.2022.816275.


Glycosylation of Plant-Produced Immunoglobulins.

Goritzer K, Strasser R Exp Suppl. 2021; 112:519-543.

PMID: 34687021 DOI: 10.1007/978-3-030-76912-3_16.